• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

阿米卡星及其他十种氨基糖苷类抗生素对庆大霉素耐药菌株的体外活性

In vitro activity of amikacin and ten other aminoglycoside antibiotics against gentamicin-resistant bacterial strains.

作者信息

Reyonolds A V, Hamilton-Miller J M, Brumfitt W

出版信息

J Infect Dis. 1976 Nov;134 SUPPL:S291-6. doi: 10.1093/infdis/135.supplement_2.s291.

DOI:10.1093/infdis/135.supplement_2.s291
PMID:62815
Abstract

Sixty-nine strains of gentamicin-resistant gram-negative bacilli obtained from different geographical sources were tested for susceptibility to 11 aminoglycoside antibiotics. From the results of determinations of minimal inhibitory concentrations, patterns of resistance were established for 45 strains of Enterobacteriaceae and 24 strains of Pseudomonas aeruginosa. Overall, 81% of the strains were sensitive to amikacin and 33% of the strains were sensitive to butirosin, the next most active compound. Results indicated that 54% of the P. aeruginosa strains were sensitive to amikacin and 33% were sensitive to tobramycin. From resistance patterns, enzymes responsible for inactivation of the antibiotics were deduced. The most common enzyme was aminoglycoside nucleotidyltransferase(2''), either alone or combined with either aminoglycoside phosphotransferase(3')-I or aminoglycoside phosphotransferase(3')-II. Aminoglycoside acetyltransferase(2) was identified exclusively in strains of Providencia stuartii. Specific enzymes could not be identified for 30 strains, 21 of which were P. aeruginosa.

摘要

对从不同地理来源分离得到的69株耐庆大霉素革兰氏阴性杆菌进行了11种氨基糖苷类抗生素的药敏试验。根据最低抑菌浓度测定结果,确定了45株肠杆菌科细菌和24株铜绿假单胞菌的耐药模式。总体而言,81%的菌株对阿米卡星敏感,33%的菌株对下一个活性最强的化合物布替罗星敏感。结果表明,54%的铜绿假单胞菌菌株对阿米卡星敏感,33%对妥布霉素敏感。根据耐药模式推断出负责抗生素失活的酶。最常见的酶是氨基糖苷核苷酸转移酶(2''),单独存在或与氨基糖苷磷酸转移酶(3')-I或氨基糖苷磷酸转移酶(3')-II联合存在。氨基糖苷乙酰转移酶(2)仅在斯氏普罗威登斯菌菌株中鉴定到。30株菌株无法鉴定出特定的酶,其中21株为铜绿假单胞菌。

相似文献

1
In vitro activity of amikacin and ten other aminoglycoside antibiotics against gentamicin-resistant bacterial strains.阿米卡星及其他十种氨基糖苷类抗生素对庆大霉素耐药菌株的体外活性
J Infect Dis. 1976 Nov;134 SUPPL:S291-6. doi: 10.1093/infdis/135.supplement_2.s291.
2
Amikacin, an aminoglycoside with marked activity against antibiotic-resistant clinical isolates.阿米卡星,一种对耐药临床分离株具有显著活性的氨基糖苷类抗生素。
J Infect Dis. 1976 Nov;134 SUPPL:S249-61. doi: 10.1093/infdis/135.supplement_2.s249.
3
Suceptibility of aminoglycoside-resistant gram-negative bacilli to amikacin: delineation of individual resistance patterns.耐氨基糖苷类革兰氏阴性杆菌对阿米卡星的敏感性:个体耐药模式的描述。
J Infect Dis. 1976 Nov;134 SUPPL:S280-5. doi: 10.1093/infdis/135.supplement_2.s280.
4
Susceptibility of current clinical isolates of Pseudomonas aeruginosa and enteric gram-negative bacilli to amikacin and other aminoglycoside antibiotics.铜绿假单胞菌和肠道革兰氏阴性杆菌的当前临床分离株对阿米卡星和其他氨基糖苷类抗生素的敏感性。
J Infect Dis. 1976 Nov;134 SUPPL:S394-90.
5
Susceptibility of recently isolated bacteria to amikacin in vitro: comparisons with four other aminoglycoside antibiotics.近期分离出的细菌对阿米卡星的体外敏感性:与其他四种氨基糖苷类抗生素的比较。
J Infect Dis. 1976 Nov;134 SUPPL:S297-307. doi: 10.1093/infdis/135.supplement_2.s297.
6
[New aminoglycoside desoxystreptamine-containing antibiotics].[新型含去氧链霉胺的氨基糖苷类抗生素]
Antibiotiki. 1976 Nov;21(11):1033-50.
7
In vitro susceptibility of recently isolated gram-negative bacteria to gentamicin, sisomicin, tobramycin, and amikacin.近期分离出的革兰氏阴性菌对庆大霉素、西索米星、妥布霉素和阿米卡星的体外敏感性
J Infect Dis. 1976 Nov;134 SUPPL:S271-4. doi: 10.1093/infdis/135.supplement_2.s271.
8
In vitro susceptibility of gentamicin-resistant Enterobacteriaceae and Pseudomonas aeruginosa to aminoglycoside antibiotics.耐庆大霉素肠杆菌科细菌和铜绿假单胞菌对氨基糖苷类抗生素的体外敏感性
Bol Asoc Med P R. 1983 Jul;75(7):305-7.
9
[Antimicrobial effectiveness of sisomicin. I: In vitro activity of sisomicin compared with gentamicin, tobramycin, amikacin and kanamycin (author's transl)].西索米星的抗菌效能。I:西索米星与庆大霉素、妥布霉素、阿米卡星和卡那霉素相比的体外活性(作者译)
Infection. 1976;4(2):35-41. doi: 10.1007/BF01638346.
10
Newer aminoglycosides--amikacin and tobramycin: an in-vitro comparison with kanamycin and gentamicin.新型氨基糖苷类药物——阿米卡星和妥布霉素:与卡那霉素和庆大霉素的体外比较。
Br Med J. 1974 Sep 28;3(5934):778-80. doi: 10.1136/bmj.3.5934.778.

引用本文的文献

1
Externally validated population pharmacokinetics of amikacin and evaluation of dosage regimen based on achieved serum concentrations in neonates.阿米卡星的外部验证群体药代动力学及基于新生儿血清浓度实现情况的给药方案评估。
Antimicrob Agents Chemother. 2025 Aug 6;69(8):e0081825. doi: 10.1128/aac.00818-25. Epub 2025 Jul 17.
2
Aminoglycoside resistance in Pseudomonas aeruginosa.铜绿假单胞菌中的氨基糖苷类耐药性。
Antimicrob Agents Chemother. 2005 Feb;49(2):479-87. doi: 10.1128/AAC.49.2.479-487.2005.
3
Frequency of resistance to kanamycin, tobramycin, netilmicin, and amikacin in gentamicin-resistant gram-negative bacteria.
庆大霉素耐药革兰氏阴性菌对卡那霉素、妥布霉素、奈替米星和阿米卡星的耐药频率。
Antimicrob Agents Chemother. 1978 Jan;13(1):70-3. doi: 10.1128/AAC.13.1.70.